Kyndaron Reinier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kyndaron Reinier has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Sumeet S. Chugh
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States
24 shared publications - Harpriya Chugh
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States
17 shared publications - Audrey Uy-Evanado
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States
15 shared publications Audrey Uy-Evanado
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System
8 shared publications- Jonathan Jui
Department of Emergency Medicine, Oregon Health and Science University, Portland (J.J.).
8 shared publications - Thien Tan Tri Tai Truyen
Faculty of Medicine, Nam Can Tho University, Can Tho City, Vietnam
8 shared publications
Latest Publications
- Open Access
Divergent Causes of Death After Ischemic and Hemorrhagic Stroke in the Reperfusion Era: A Contemporary Cohort Study
Background: Contemporary data on long-term, cause-specific mortality among stroke survivors are sparse, and much of the existing evidence derives from studies performed before the modern reperfusion era. We sought to characterize long-term cause-specific mortality among stroke survivors to discharge (differentiated by stroke subtype) when compared to in-hospital stroke decedents treated under contemporary standards of care. Methods: Using a hybrid billing-code/imaging and large language model-assisted chart-review pipeline, we identified adults hospitalized for ischemic or hemorrhagic stroke in the Observational Study of Cardiac Arrest Risk (OSCAR) cohort (Cedars-Sinai Health System, Los Angeles) between 2017 and 2020, followed through June 30, 2025. Cause of death was determined and classified into 10 categories. Results: Among 1,344 stroke patients (mean age 74.0 ± 14.9 years; ischemic n=1,036 [77.1%], hemorrhagic n=308 [22.9%]), 203 (15.1%) did not survive the index stroke. Of the 1,141 discharged survivors, 625 (54.8%) died over a median follow-up of 5.2 years. Cerebrovascular causes predominated during index stroke hospitalization (36.0%) but accounted for only 15.5% of post-stroke discharge deaths. Among ischemic stroke survivors, cardiac disease was the leading cause of death (31.6%), with sudden cardiac arrest alone accounting for 10.9% of deaths. Among hemorrhagic stroke survivors, cancer (38.9%) was the leading cause of death. Despite these divergent cause-of-death profiles, overall survival did not differ significantly by subtype (median 5.5 vs 5.8 years; P =0.90). Conclusions: In this contemporary, reperfusion-era cohort, causes of death shifted from cerebrovascular predominance in the acute phase to heart disease/cardiac arrest after ischemic stroke, and malignancy after hemorrhagic stroke. These findings argue for development of subtype-specific post-stroke surveillance, including structured longitudinal cardiac and sudden-death risk assessment for ischemic stroke survivors.
Open AccessDivergent Causes of Death After Ischemic and Hemorrhagic Stroke in the Reperfusion Era: A Contemporary Cohort Study
Background: Contemporary data on long-term, cause-specific mortality among stroke survivors are sparse, and much of the existing evidence derives from studies performed before the modern reperfusion era. We sought to characterize long-term cause-specific mortality among stroke survivors to discharge (differentiated by stroke subtype) when compared to in-hospital stroke decedents treated under contemporary standards of care. Methods: Using a hybrid billing-code/imaging and large language model-assisted chart-review pipeline, we identified adults hospitalized for ischemic or hemorrhagic stroke in the Observational Study of Cardiac Arrest Risk (OSCAR) cohort (Cedars-Sinai Health System, Los Angeles) between 2017 and 2020, followed through June 30, 2025. Cause of death was determined and classified into 10 categories. Results: Among 1,344 stroke patients (mean age 74.0 ± 14.9 years; ischemic n=1,036 [77.1%], hemorrhagic n=308 [22.9%]), 203 (15.1%) did not survive the index stroke. Of the 1,141 discharged survivors, 625 (54.8%) died over a median follow-up of 5.2 years. Cerebrovascular causes predominated during index stroke hospitalization (36.0%) but accounted for only 15.5% of post-stroke discharge deaths. Among ischemic stroke survivors, cardiac disease was the leading cause of death (31.6%), with sudden cardiac arrest alone accounting for 10.9% of deaths. Among hemorrhagic stroke survivors, cancer (38.9%) was the leading cause of death. Despite these divergent cause-of-death profiles, overall survival did not differ significantly by subtype (median 5.5 vs 5.8 years; P =0.90). Conclusions: In this contemporary, reperfusion-era cohort, causes of death shifted from cerebrovascular predominance in the acute phase to heart disease/cardiac arrest after ischemic stroke, and malignancy after hemorrhagic stroke. These findings argue for development of subtype-specific post-stroke surveillance, including structured longitudinal cardiac and sudden-death risk assessment for ischemic stroke survivors.
- Open Access
Distinct Sex-Associated Phenotypes of Sudden Cardiac Arrest Across Clinical, ECG, and Echocardiographic Domains: Replication in Two Communities and Comparison with the Framingham Heart Study
Background: Sex differences in sudden cardiac arrest (SCA) incidence and outcomes are well established, but risk stratification underperforms in women. It is important to delineate sex-specific patterns in SCA across clinical, electrocardiographic, and echocardiographic domains. Methods: We studied out-of-hospital SCA cases from the Oregon Sudden Unexpected Death Study (ORSUDS; Portland, 2002–2020; discovery) and Prediction of Sudden Death in Multi-Ethnic Communities (PRESTO; Ventura County, 2015–2024; external replication). Sex differences in 38 comorbidities, 19 ECG and 12 echocardiographic measures were estimated using multivariable-adjusted logistic regression. Female sex was the modeled dependent measure (male as reference). ORSUDS estimates were compared with those in the Framingham Heart Study (FHS), a community-based reference cohort, using FDR-adjusted Cochran Q tests. Results: Among 5130 ORSUDS cases, 1715 (33.4%) were women (median age, 70.4 years [IQR, 58.7–81.8]) and 3415 (66.6%) were men (65.6 [55.0–76.8]). Compared with men, women had higher BMI (per 5 kg/m², 1.11 [1.08–1.15]) and higher odds of thyroid disease (2.56 [2.17–3.13]), asthma (2.33 [1.92–2.86]), mood disorder (2.17 [1.85–2.50]), dementia (1.27 [1.02–1.56]), and left ventricular hypertrophy (LVH, 3.13 [2.44–4.00]). Women also had lower odds of coronary artery disease (0.61 [0.52–0.71]), atrial fibrillation (0.67 [0.56–0.79]), prolonged QTc (0.45 [0.35–0.57]), prolonged PR (0.53 [0.41–0.68]), premature contractions (0.77 [0.60–0.98]), sleep apnea (0.53 [0.43–0.65]), and reduced LVEF (0.40 [0.29–0.54]). Most findings were replicated in PRESTO (n=2719). In contrast, several of these differences were reversed in the community (FHS, n=3539;FDR-significant): prolonged QTc was more common in women, whereas LVH, dementia, heart failure, and higher BMI were more common in men. Conclusions: Sex differences among SCA cases were mostly reproducible in SCA cohorts, and distinct from sex-related patterns in the community. These results have implications for development of sex-specific SCA risk assessment and prevention strategies. Clinical Perspective: What is new?: This study is the first community-based analysis to comprehensively characterize pre-arrest sex-associated profiles across clinical, ECG, and echocardiographic domains, externally validate them, and compare them with a community reference population. Women with SCA were more strongly associated with non-cardiac comorbidities, LVH, preserved LVEF, and mitral valve abnormalities, whereas male cases were characterized by coronary and peripheral vascular disease, atrial fibrillation, prolonged PR and QTc intervals, premature contractions, and reduced LVEF. Several sex associations, including QTc prolongation, LVH, body mass index, heart failure, and dementia, differed in magnitude or direction from patterns in the community reference population. What are the clinical implications?: Our findings suggest candidate features for future sex specific risk factor analyses and potential components for sex-specific risk models for SCA. Clinicians may need to recognize the critical need to extend beyond dependence on just the value of the left ventricular ejection fraction for SCA risk prediction, especially in women.
Open AccessDistinct Sex-Associated Phenotypes of Sudden Cardiac Arrest Across Clinical, ECG, and Echocardiographic Domains: Replication in Two Communities and Comparison with the Framingham Heart Study
Background: Sex differences in sudden cardiac arrest (SCA) incidence and outcomes are well established, but risk stratification underperforms in women. It is important to delineate sex-specific patterns in SCA across clinical, electrocardiographic, and echocardiographic domains. Methods: We studied out-of-hospital SCA cases from the Oregon Sudden Unexpected Death Study (ORSUDS; Portland, 2002–2020; discovery) and Prediction of Sudden Death in Multi-Ethnic Communities (PRESTO; Ventura County, 2015–2024; external replication). Sex differences in 38 comorbidities, 19 ECG and 12 echocardiographic measures were estimated using multivariable-adjusted logistic regression. Female sex was the modeled dependent measure (male as reference). ORSUDS estimates were compared with those in the Framingham Heart Study (FHS), a community-based reference cohort, using FDR-adjusted Cochran Q tests. Results: Among 5130 ORSUDS cases, 1715 (33.4%) were women (median age, 70.4 years [IQR, 58.7–81.8]) and 3415 (66.6%) were men (65.6 [55.0–76.8]). Compared with men, women had higher BMI (per 5 kg/m², 1.11 [1.08–1.15]) and higher odds of thyroid disease (2.56 [2.17–3.13]), asthma (2.33 [1.92–2.86]), mood disorder (2.17 [1.85–2.50]), dementia (1.27 [1.02–1.56]), and left ventricular hypertrophy (LVH, 3.13 [2.44–4.00]). Women also had lower odds of coronary artery disease (0.61 [0.52–0.71]), atrial fibrillation (0.67 [0.56–0.79]), prolonged QTc (0.45 [0.35–0.57]), prolonged PR (0.53 [0.41–0.68]), premature contractions (0.77 [0.60–0.98]), sleep apnea (0.53 [0.43–0.65]), and reduced LVEF (0.40 [0.29–0.54]). Most findings were replicated in PRESTO (n=2719). In contrast, several of these differences were reversed in the community (FHS, n=3539;FDR-significant): prolonged QTc was more common in women, whereas LVH, dementia, heart failure, and higher BMI were more common in men. Conclusions: Sex differences among SCA cases were mostly reproducible in SCA cohorts, and distinct from sex-related patterns in the community. These results have implications for development of sex-specific SCA risk assessment and prevention strategies. Clinical Perspective: What is new?: This study is the first community-based analysis to comprehensively characterize pre-arrest sex-associated profiles across clinical, ECG, and echocardiographic domains, externally validate them, and compare them with a community reference population. Women with SCA were more strongly associated with non-cardiac comorbidities, LVH, preserved LVEF, and mitral valve abnormalities, whereas male cases were characterized by coronary and peripheral vascular disease, atrial fibrillation, prolonged PR and QTc intervals, premature contractions, and reduced LVEF. Several sex associations, including QTc prolongation, LVH, body mass index, heart failure, and dementia, differed in magnitude or direction from patterns in the community reference population. What are the clinical implications?: Our findings suggest candidate features for future sex specific risk factor analyses and potential components for sex-specific risk models for SCA. Clinicians may need to recognize the critical need to extend beyond dependence on just the value of the left ventricular ejection fraction for SCA risk prediction, especially in women.
- Open Access
Beyond ICD Codes: Fine-Tuning LLMs for In-Hospital Cardiac Arrest Identification from EHR Notes
Background: Identification of in-hospital cardiac arrest (IHCA) through manual chart abstraction is the gold standard, but its time-consuming and resource-intensive, which naturally limits its practicality. Diagnostic codes provide an accessible automated alternative, but prior work has shown this method of extraction has poor sensitivity and poor positive predictive value. More accurate and scalable automated methods are needed to support IHCA surveillance and research. Methods: We developed large language model (LLM)-based systems that incorporated physician-defined clinical knowledge through guideline-enriched prompting, supervised finetuning, and a self-correction procedure. The systems identified IHCA events and their locations from electronic health record notes. Performance was evaluated at the encounter level against physician-adjudicated chart review and compared with ICD-code–based identification. Results: Compared with an ICD-code–based algorithm (precision 0.68, recall 0.91, F1 score 0.78), the supervised fine-tuned LLM offered substantially better performance for IHCA identification on a curated evaluation corpus, reaching a precision of 0.88, a recall of 1.00, and an F1 score of 0.94. When tested on a larger, unselected validation cohort of 45,525 encounters, a separate LLM configuration—relying on guideline-enriched prompting and a self-correction procedure rather than fine-tuning—achieved a precision of 0.79 for encounter-level IHCA identification, meaning most encounters flagged by the model were genuine IHCA cases. The fine-tuned LLM underperformed on this cohort due to its inability to self-correct its decisions, an issue that can be mitigated by having a separate model perform the correction step. Conclusion: Explicit integration of clinical knowledge through prompting and supervised fine-tuning enabled accurate identification of IHCA events and locations from routine clinical documentation. In a two-pass workflow, these systems could prioritize encounters for clinician adjudication, reduce manual screening requirements, and support more scalable IHCA surveillance and registry development.
Open AccessBeyond ICD Codes: Fine-Tuning LLMs for In-Hospital Cardiac Arrest Identification from EHR Notes
Background: Identification of in-hospital cardiac arrest (IHCA) through manual chart abstraction is the gold standard, but its time-consuming and resource-intensive, which naturally limits its practicality. Diagnostic codes provide an accessible automated alternative, but prior work has shown this method of extraction has poor sensitivity and poor positive predictive value. More accurate and scalable automated methods are needed to support IHCA surveillance and research. Methods: We developed large language model (LLM)-based systems that incorporated physician-defined clinical knowledge through guideline-enriched prompting, supervised finetuning, and a self-correction procedure. The systems identified IHCA events and their locations from electronic health record notes. Performance was evaluated at the encounter level against physician-adjudicated chart review and compared with ICD-code–based identification. Results: Compared with an ICD-code–based algorithm (precision 0.68, recall 0.91, F1 score 0.78), the supervised fine-tuned LLM offered substantially better performance for IHCA identification on a curated evaluation corpus, reaching a precision of 0.88, a recall of 1.00, and an F1 score of 0.94. When tested on a larger, unselected validation cohort of 45,525 encounters, a separate LLM configuration—relying on guideline-enriched prompting and a self-correction procedure rather than fine-tuning—achieved a precision of 0.79 for encounter-level IHCA identification, meaning most encounters flagged by the model were genuine IHCA cases. The fine-tuned LLM underperformed on this cohort due to its inability to self-correct its decisions, an issue that can be mitigated by having a separate model perform the correction step. Conclusion: Explicit integration of clinical knowledge through prompting and supervised fine-tuning enabled accurate identification of IHCA events and locations from routine clinical documentation. In a two-pass workflow, these systems could prioritize encounters for clinician adjudication, reduce manual screening requirements, and support more scalable IHCA surveillance and registry development.
- 25 August 2026
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 5 (9) , 779-781
The neglected role of lethal arrhythmia in the sudden death of stroke survivors
- 25 August 2026
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 5 (9) , 779-781
The neglected role of lethal arrhythmia in the sudden death of stroke survivors
- 8 July 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (8) , e014647
Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest
BACKGROUND: At least 50% of individuals who suffer sudden cardiac arrest (SCA) have warning symptoms before their SCA, but these are not sufficient to predict imminent SCA (ISCA). We hypothesized that combining symptoms with clinical profile could effectively predict ISCA. METHODS: In 2 community-based studies of SCA in Oregon and California, survivors of SCA who had experienced warning symptoms and called 911 (n=364) were compared with control subjects (n=313) who also called 911 for similar symptoms but did not have SCA. Symptom information was obtained directly from interviews as well as prehospital emergency records. We used machine learning to identify predictive combinations of symptoms and clinical features in this case-control study. The area under the receiver operating characteristic curve (AUC) and 5-fold cross-validation were used to assess model performance and stability. RESULTS: Warning symptom-clinical profile combinations were successfully identified. The combination of chest pain and known heart failure predicted ISCA among males, while chest pain and known coronary artery disease predicted ISCA among females (AUC=0.788). With dyspnea, both history of coronary artery disease and heart failure were predictors (AUC=0.745). In the absence of chest pain or dyspnea, seizure-like symptoms, coronary artery disease, and heart failure were predictors (AUC, 0.775). 5-fold cross-validation produced consistent results. CONCLUSIONS: Combinations of warning symptoms and clinical features distinguished individuals with SCA from individuals without SCA with good accuracy (AUCs, 0.745–0.788). These findings have implications for clinical triage of ISCA warning symptoms in emergency settings and warrant investigation in larger studies.
- 8 July 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (8) , e014647
Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest
BACKGROUND: At least 50% of individuals who suffer sudden cardiac arrest (SCA) have warning symptoms before their SCA, but these are not sufficient to predict imminent SCA (ISCA). We hypothesized that combining symptoms with clinical profile could effectively predict ISCA. METHODS: In 2 community-based studies of SCA in Oregon and California, survivors of SCA who had experienced warning symptoms and called 911 (n=364) were compared with control subjects (n=313) who also called 911 for similar symptoms but did not have SCA. Symptom information was obtained directly from interviews as well as prehospital emergency records. We used machine learning to identify predictive combinations of symptoms and clinical features in this case-control study. The area under the receiver operating characteristic curve (AUC) and 5-fold cross-validation were used to assess model performance and stability. RESULTS: Warning symptom-clinical profile combinations were successfully identified. The combination of chest pain and known heart failure predicted ISCA among males, while chest pain and known coronary artery disease predicted ISCA among females (AUC=0.788). With dyspnea, both history of coronary artery disease and heart failure were predictors (AUC=0.745). In the absence of chest pain or dyspnea, seizure-like symptoms, coronary artery disease, and heart failure were predictors (AUC, 0.775). 5-fold cross-validation produced consistent results. CONCLUSIONS: Combinations of warning symptoms and clinical features distinguished individuals with SCA from individuals without SCA with good accuracy (AUCs, 0.745–0.788). These findings have implications for clinical triage of ISCA warning symptoms in emergency settings and warrant investigation in larger studies.
- 7 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (13) , e049853
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular Events
Background: Although cardiovascular events increase sudden cardiac arrest (SCA) risk, the impact of recurrent events on subsequent SCA risk in a contemporary population is unknown. This study assessed whether patients with a first‐time acute coronary syndrome (ACS) or heart failure (HF) hospitalization who experience a recurrent cardiovascular event have increased SCA risk. Methods: The OSCAR (Observational Study of Cardiac Arrest Risk) is a prospective cohort with adjudicated SCA outcomes. The current study followed up patients who survived a first ACS or HF hospitalization (the index ACS or HF cohorts) for recurrent cardiovascular events and SCA. Recurrent event was a time‐dependent variable in Cox models predicting SCA. Findings were validated in the FHS (Framingham Heart Study). Results: Among 2946 patients in the index ACS cohort, incidence of SCA was higher following a recurrent ACS event than without (3.70 versus 1.28 per 100 patient‐years). A recurrent ACS event was associated with higher risk of SCA (adjusted hazard ratio [HR], 3.15 [95% CI, 2.06–4.83]; P P P =0.0002); the association was not significant for recurrent HF (HR, 1.49 [95% CI, 0.73–3.03]; P =0.27). Conclusions: Recurrent events were associated with higher risk of SCA; dynamic clinical trajectories of recurrent cardiovascular events may inform prevention of SCA.
- 7 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (13) , e049853
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular Events
Background: Although cardiovascular events increase sudden cardiac arrest (SCA) risk, the impact of recurrent events on subsequent SCA risk in a contemporary population is unknown. This study assessed whether patients with a first‐time acute coronary syndrome (ACS) or heart failure (HF) hospitalization who experience a recurrent cardiovascular event have increased SCA risk. Methods: The OSCAR (Observational Study of Cardiac Arrest Risk) is a prospective cohort with adjudicated SCA outcomes. The current study followed up patients who survived a first ACS or HF hospitalization (the index ACS or HF cohorts) for recurrent cardiovascular events and SCA. Recurrent event was a time‐dependent variable in Cox models predicting SCA. Findings were validated in the FHS (Framingham Heart Study). Results: Among 2946 patients in the index ACS cohort, incidence of SCA was higher following a recurrent ACS event than without (3.70 versus 1.28 per 100 patient‐years). A recurrent ACS event was associated with higher risk of SCA (adjusted hazard ratio [HR], 3.15 [95% CI, 2.06–4.83]; P P P =0.0002); the association was not significant for recurrent HF (HR, 1.49 [95% CI, 0.73–3.03]; P =0.27). Conclusions: Recurrent events were associated with higher risk of SCA; dynamic clinical trajectories of recurrent cardiovascular events may inform prevention of SCA.
- Open Access
A Clinical Prediction Model for Sudden Cardiac Arrest Presenting as Pulseless Electrical Activity
Background: The incidence of sudden cardiac arrest (SCA) manifesting as pulseless electrical activity (PEA) has increased, and survival remains extremely low. Methods for early identification and management of high-risk individuals are needed, but no clinical risk scores currently exist to predict PEA-SCA. Our objective was to develop and validate a clinical prediction model for PEA-SCA. Methods: From an ongoing prospective, population-based study of SCA in Portland, Oregon (catchment pop. ≈1 M, 2002-2020), we identified PEA-SCA adults. Lifetime clinical records were compared with those of a control group with >50% prevalence of significant coronary disease. Prediction models were constructed using backwards stepwise logistic regression in a training dataset (67%) and evaluated in a validation dataset (33%). Model discrimination was assessed using receiver operating characteristic curves (C statistic). External validation was performed in a geographically distinct population in Ventura County, California (population ≈850,000, 2015-2022). Results: The final clinical algorithm (PEA-Risk) incorporating 12 clinical, electrocardiogram and medication variables demonstrated strong discrimination in the training dataset (C statistic = 0.860 [95% CI: 0.838-0.881]) and remained robust in internal (C statistic = 0.832 [95% CI: 0.800-0.865]) and external validation datasets (C statistic = 0.704 [95% CI: 0.665-0.743]). Conclusions: We developed and externally validated a clinical algorithm for predicting PEA-SCA. Given the low rates of successful resuscitation after PEA arrest, this risk prediction tool may enable earlier identification and prevention of PEA-SCA. Clinical Perspective: What is known: The proportion of SCA presenting as pulseless electrical activity (PEA) is increasing, and survival from these events remains extremely low. The are no available methods for clinical risk prediction of these events. What the study adds: The present study constructs and replicates a risk score for prediction of SCA manifesting with PEA using widely available clinical and noninvasive markers. These findings have implications for developing prevention and management strategies for individuals at high risk of PEA-SCA.
Open AccessA Clinical Prediction Model for Sudden Cardiac Arrest Presenting as Pulseless Electrical Activity
Background: The incidence of sudden cardiac arrest (SCA) manifesting as pulseless electrical activity (PEA) has increased, and survival remains extremely low. Methods for early identification and management of high-risk individuals are needed, but no clinical risk scores currently exist to predict PEA-SCA. Our objective was to develop and validate a clinical prediction model for PEA-SCA. Methods: From an ongoing prospective, population-based study of SCA in Portland, Oregon (catchment pop. ≈1 M, 2002-2020), we identified PEA-SCA adults. Lifetime clinical records were compared with those of a control group with >50% prevalence of significant coronary disease. Prediction models were constructed using backwards stepwise logistic regression in a training dataset (67%) and evaluated in a validation dataset (33%). Model discrimination was assessed using receiver operating characteristic curves (C statistic). External validation was performed in a geographically distinct population in Ventura County, California (population ≈850,000, 2015-2022). Results: The final clinical algorithm (PEA-Risk) incorporating 12 clinical, electrocardiogram and medication variables demonstrated strong discrimination in the training dataset (C statistic = 0.860 [95% CI: 0.838-0.881]) and remained robust in internal (C statistic = 0.832 [95% CI: 0.800-0.865]) and external validation datasets (C statistic = 0.704 [95% CI: 0.665-0.743]). Conclusions: We developed and externally validated a clinical algorithm for predicting PEA-SCA. Given the low rates of successful resuscitation after PEA arrest, this risk prediction tool may enable earlier identification and prevention of PEA-SCA. Clinical Perspective: What is known: The proportion of SCA presenting as pulseless electrical activity (PEA) is increasing, and survival from these events remains extremely low. The are no available methods for clinical risk prediction of these events. What the study adds: The present study constructs and replicates a risk score for prediction of SCA manifesting with PEA using widely available clinical and noninvasive markers. These findings have implications for developing prevention and management strategies for individuals at high risk of PEA-SCA.
- Open Access
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular Events
Background: Emerging evidence suggests that dynamic risk assessment may enhance sudden cardiac arrest (SCA) risk stratification. While cardiovascular events, including acute coronary syndrome (ACS) and heart failure (HF) hospitalization, are associated with increased SCA risk, the impact of recurrent events on subsequent SCA risk in a contemporary, real-world population is unknown. This study aimed to assess whether patients with a first-time ACS or HF hospitalization who experience a recurrent cardiovascular event have higher risk of SCA compared to those who do not. Methods: The Observational Study of Cardiac Arrest Risk (OSCAR) is a prospective cohort study with adjudicated SCA outcomes. In the current study, patients who survived a first ACS or HF hospitalization were categorized into index ACS or HF cohorts. Participants were followed for recurrent cardiovascular events and SCA. Associations between recurrent events and SCA were assessed using Cox models with recurrent event modeled as a time-dependent variable. Findings were validated in the Framingham Heart Study (FHS). Results: In the OSCAR discovery cohort, 2946 patients experienced an index ACS event. The incidence rate of SCA was higher following a recurrent ACS event than without (3.70 vs 1.28 per 100 patient-years). Recurrent ACS event was associated with a significantly higher risk of SCA (adjusted HR 3.15, 95% CI 2.06-4.83, p<0.0001). A total of 6711 patients experienced an index HF hospitalization, and the incidence rate of SCA was higher following a recurrent HF event than without (1.35 vs 0.97 per 100 patient-years). Recurrent HF hospitalization was associated with a significantly higher risk of SCA (HR 1.81, 95% CI 1.46-2.26, p<0.0001). In the FHS validation cohorts a recurrent event during follow-up was associated with a significantly higher risk of SCA in the ACS cohort (HR 2.85, 95% CI 1.66-4.90, p=0.0002), but the association was not statistically significant in the HF cohort (HR 1.49, 95% CI 0.73-3.03, p=0.27). Conclusion: Recurrent ACS event was associated with more than threefold higher risk of SCA, and a recurrent HF hospitalization with 80% higher risk of SCA. These findings suggest that dynamic clinical trajectories of recurrent cardiovascular events may inform management and prevention of SCA. Clinical Perspective: What is new?: In patients with a first acute coronary syndrome (ACS), those with a recurrent ACS event during follow-up had a threefold higher risk of sudden cardiac arrest (SCA) compared with patients without recurrence. Among patients hospitalized for heart failure (HF) for the first time, those with a subsequent HF hospitalization had nearly double the risk of SCA compared with those without recurrence. What are the Clinical Implications?: These findings indicate that individuals with recurrent cardiovascular events are at higher risk of sudden cardiac arrest. These dynamic risk trajectories may inform management of these patients as well as improved prevention of sudden cardiac arrest. Future prospective studies are needed to test these findings in larger and more diverse populations.
Open AccessDynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular Events
Background: Emerging evidence suggests that dynamic risk assessment may enhance sudden cardiac arrest (SCA) risk stratification. While cardiovascular events, including acute coronary syndrome (ACS) and heart failure (HF) hospitalization, are associated with increased SCA risk, the impact of recurrent events on subsequent SCA risk in a contemporary, real-world population is unknown. This study aimed to assess whether patients with a first-time ACS or HF hospitalization who experience a recurrent cardiovascular event have higher risk of SCA compared to those who do not. Methods: The Observational Study of Cardiac Arrest Risk (OSCAR) is a prospective cohort study with adjudicated SCA outcomes. In the current study, patients who survived a first ACS or HF hospitalization were categorized into index ACS or HF cohorts. Participants were followed for recurrent cardiovascular events and SCA. Associations between recurrent events and SCA were assessed using Cox models with recurrent event modeled as a time-dependent variable. Findings were validated in the Framingham Heart Study (FHS). Results: In the OSCAR discovery cohort, 2946 patients experienced an index ACS event. The incidence rate of SCA was higher following a recurrent ACS event than without (3.70 vs 1.28 per 100 patient-years). Recurrent ACS event was associated with a significantly higher risk of SCA (adjusted HR 3.15, 95% CI 2.06-4.83, p<0.0001). A total of 6711 patients experienced an index HF hospitalization, and the incidence rate of SCA was higher following a recurrent HF event than without (1.35 vs 0.97 per 100 patient-years). Recurrent HF hospitalization was associated with a significantly higher risk of SCA (HR 1.81, 95% CI 1.46-2.26, p<0.0001). In the FHS validation cohorts a recurrent event during follow-up was associated with a significantly higher risk of SCA in the ACS cohort (HR 2.85, 95% CI 1.66-4.90, p=0.0002), but the association was not statistically significant in the HF cohort (HR 1.49, 95% CI 0.73-3.03, p=0.27). Conclusion: Recurrent ACS event was associated with more than threefold higher risk of SCA, and a recurrent HF hospitalization with 80% higher risk of SCA. These findings suggest that dynamic clinical trajectories of recurrent cardiovascular events may inform management and prevention of SCA. Clinical Perspective: What is new?: In patients with a first acute coronary syndrome (ACS), those with a recurrent ACS event during follow-up had a threefold higher risk of sudden cardiac arrest (SCA) compared with patients without recurrence. Among patients hospitalized for heart failure (HF) for the first time, those with a subsequent HF hospitalization had nearly double the risk of SCA compared with those without recurrence. What are the Clinical Implications?: These findings indicate that individuals with recurrent cardiovascular events are at higher risk of sudden cardiac arrest. These dynamic risk trajectories may inform management of these patients as well as improved prevention of sudden cardiac arrest. Future prospective studies are needed to test these findings in larger and more diverse populations.
- Open Access
- 17 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (6) , oeaf131
Markers of sudden cardiac death associated with the ventricular-paced 12-lead ECG
Introduction: ECG markers are associated with increased risk of sudden cardiac arrest (SCA) on the sinus rhythm ECG. A sizeable subgroup of patients at risk receives cardiac implantable electrical devices, but there are no known markers of SCA risk on the ventricular-paced (VP) ECG. Methods and results: We conducted a case-control analysis within a community-based SCA study in Oregon USA (2002–2020; ∼1 million catchment population) with validation in an identically designed study in California USA (2015–2023; ∼850 000 catchment population). SCA cases included adults (≥18 years) with archived VP ECGs obtained prior and unrelated to their SCA. Controls met the same ECG criteria but without history of ventricular arrhythmias or SCA. The discovery analysis included 158 participants (119 SCA, 39 controls), mean age 76.9 ± 11.8 years. SCA cases had a higher ventricular rate (74.9 ± 16.0 bpm vs. 69.3 ± 12.0 bpm, P = 0.05), longer corrected QT interval (QTc; 525.9 ± 49.9 ms vs. 493.9 ± 31.0 ms, P < 0.001) and longer Tpeak-Tend (Tpe; 111.8 ± 23.3 ms vs. 95.9 ± 20.1 ms, P < 0.001). After adjustment, QTc and Tpe were significantly associated with SCA, with adjusted ORs 6.1 (95%CI: 1.4–26.2) and 7.9 (95%CI: 2.0–31.0) in the discovery population, and 6.1 (95%CI: 2.5–14.8) and 3.7 (95%CI: 1.6–8.6) in the validation population. In pooled analysis, the model combining QTc and Tpe achieved an AUC of 0.752, significantly outperforming each individually. Subjects with both prolonged QTc and Tpe had a 16-fold higher risk (adjusted OR:16.2, 95%CI: 6.0–43.6) compared to those without abnormalities. Conclusion: Abnormal myocardial repolarization measured by QTc and Tpe was independently associated with SCA. These findings suggest that the VP ECG could also predict SCA risk.
- 17 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (6) , oeaf131
Open AccessMarkers of sudden cardiac death associated with the ventricular-paced 12-lead ECG
Introduction: ECG markers are associated with increased risk of sudden cardiac arrest (SCA) on the sinus rhythm ECG. A sizeable subgroup of patients at risk receives cardiac implantable electrical devices, but there are no known markers of SCA risk on the ventricular-paced (VP) ECG. Methods and results: We conducted a case-control analysis within a community-based SCA study in Oregon USA (2002–2020; ∼1 million catchment population) with validation in an identically designed study in California USA (2015–2023; ∼850 000 catchment population). SCA cases included adults (≥18 years) with archived VP ECGs obtained prior and unrelated to their SCA. Controls met the same ECG criteria but without history of ventricular arrhythmias or SCA. The discovery analysis included 158 participants (119 SCA, 39 controls), mean age 76.9 ± 11.8 years. SCA cases had a higher ventricular rate (74.9 ± 16.0 bpm vs. 69.3 ± 12.0 bpm, P = 0.05), longer corrected QT interval (QTc; 525.9 ± 49.9 ms vs. 493.9 ± 31.0 ms, P < 0.001) and longer Tpeak-Tend (Tpe; 111.8 ± 23.3 ms vs. 95.9 ± 20.1 ms, P < 0.001). After adjustment, QTc and Tpe were significantly associated with SCA, with adjusted ORs 6.1 (95%CI: 1.4–26.2) and 7.9 (95%CI: 2.0–31.0) in the discovery population, and 6.1 (95%CI: 2.5–14.8) and 3.7 (95%CI: 1.6–8.6) in the validation population. In pooled analysis, the model combining QTc and Tpe achieved an AUC of 0.752, significantly outperforming each individually. Subjects with both prolonged QTc and Tpe had a 16-fold higher risk (adjusted OR:16.2, 95%CI: 6.0–43.6) compared to those without abnormalities. Conclusion: Abnormal myocardial repolarization measured by QTc and Tpe was independently associated with SCA. These findings suggest that the VP ECG could also predict SCA risk.
- Open Access
- 5 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (15) , e042307
Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community‐Based Study
Background: Moderate kidney dysfunction is independently associated with increased cardiovascular death. Sudden cardiac arrest (SCA) accounts for at least 25% of chronic kidney disease (CKD) death. This study aimed to evaluate the impact of moderate CKD on SCA risk. Methods: We conducted a case–control study within a community‐based investigation of SCA in the Portland, Oregon, metropolitan area from February 1, 2002, to December 31, 2020. Analysis included individuals aged 40 to 75 years who experienced SCA (cases) and individuals with no history of SCA (controls), with creatinine levels measured before SCA/enrollment. Moderate CKD was defined by an estimated glomerular filtration rate of 30 to 2 (2021 Chronic Kidney Disease Epidemiology Collaboration formula). A population‐based SCA study in southern California was used for validation. Results: We compared 2068 SCA cases and 852 controls (mean ages, 61.4±8.5 and 62.7±8.0 years, respectively; men: 69.9% and 67.4%, respectively). SCA cases had more moderate CKD (17.7% versus 14.7%, P 2 , P 2 estimated glomerular filtration rate drop to <90 increased SCA risk (odds ratio, 1.24 [95% CI, 1.18–1.31]). Similar findings were observed in the validation cohort (817 SCA and 3249 controls), where moderate CKD was associated with SCA (odds ratio, 1.54 [95% CI, 1.18–2.00]). Conclusions: Moderate CKD is associated with an increased risk of SCA in the general population. Further research into the potential integration of moderate renal dysfunction into SCA risk stratification are warranted.
- 5 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (15) , e042307
Open AccessModerate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community‐Based Study
Background: Moderate kidney dysfunction is independently associated with increased cardiovascular death. Sudden cardiac arrest (SCA) accounts for at least 25% of chronic kidney disease (CKD) death. This study aimed to evaluate the impact of moderate CKD on SCA risk. Methods: We conducted a case–control study within a community‐based investigation of SCA in the Portland, Oregon, metropolitan area from February 1, 2002, to December 31, 2020. Analysis included individuals aged 40 to 75 years who experienced SCA (cases) and individuals with no history of SCA (controls), with creatinine levels measured before SCA/enrollment. Moderate CKD was defined by an estimated glomerular filtration rate of 30 to 2 (2021 Chronic Kidney Disease Epidemiology Collaboration formula). A population‐based SCA study in southern California was used for validation. Results: We compared 2068 SCA cases and 852 controls (mean ages, 61.4±8.5 and 62.7±8.0 years, respectively; men: 69.9% and 67.4%, respectively). SCA cases had more moderate CKD (17.7% versus 14.7%, P 2 , P 2 estimated glomerular filtration rate drop to <90 increased SCA risk (odds ratio, 1.24 [95% CI, 1.18–1.31]). Similar findings were observed in the validation cohort (817 SCA and 3249 controls), where moderate CKD was associated with SCA (odds ratio, 1.54 [95% CI, 1.18–2.00]). Conclusions: Moderate CKD is associated with an increased risk of SCA in the general population. Further research into the potential integration of moderate renal dysfunction into SCA risk stratification are warranted.